SARS-CoV-2 Omicron Spike Protein and Antibodies Available content piece image

Product

SARS-CoV-2 Omicron Spike Protein and Antibodies Available

Name: SARS-CoV-2 Omicron Spike Protein and Antibodies Available
Brand: Sino Biological Inc

Several new variants of SARS-CoV-2 virus have emerged in recent months. The Alpha, Gamma, Beta, Delta, and the most recent Omicron are particular concerning because of their high prevalence. A subset of the mutations identified in the RBD domain of the spike protein occurs in more than one strain. These convergent mutations are of high interest because they may be the cause of the increased transmissibility. Sino Biological has launched RBD and Spike proteins of these variants.

SARS-CoV-2 Omicron Spike Protein & Antibodies Available

Sino Biological has developed recombinant Omicron Spike RBD Protein and Antibody reacting with Omicron to support the study of Omicron variant. More Omicron antigens, including B.1.1.529 S-ECD, S1, and Nucleocapsid, are coming soon.

Recombinant RBD/Spike and Nucleocapsid Protein Variants

Sino Biological has developed a panel of recombinant RBD/Spike and nucleocapsid protein variants which can be used to evaluate the efficacy of the antibodies and vaccination.

Learn More Recombinant SARS-CoV-2 Variants

About Sino Biological Inc

Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offers pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates

Chosen for You